Epithalon: A Research Overview of the Longevity Tetrapeptide: Research Overview

Epithalon (also written as Epitalon) is a synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly (AEDG) and CAS number 307297-39-8. It was developed by Professor Vladimir Khavinson and his research group at the St Petersburg Institute of Bioregulation and Gerontology, where it was derived from Epithalamin — a polypeptide extract originally isolated from bovine pineal gland tissue. The synthetic form was designed to replicate the bioregulatory activity attributed to the natural extract, enabling more precise investigation in controlled laboratory settings.

With a molecular weight of 390.35 g/mol, Epithalon is among the smallest bioregulatory peptides studied in the context of cellular ageing. Its compact four-residue structure has been the subject of a substantial body of preclinical research spanning several decades, with particular focus on telomerase activity, pineal gland biology, and cellular oxidative stress pathways.

Telomerase Activation and Telomere Elongation

One of the most widely cited areas of Epithalon research concerns its relationship with telomerase — the enzyme responsible for maintaining telomere length during cell division. Telomeres are the protective caps at the ends of chromosomes, and their progressive shortening with each division is a well-characterised marker of cellular ageing.

In vitro studies using human HeLa cells and fetal lung fibroblasts (cell line 602/17) demonstrated that Epithalon activated the catalytic subunit of telomerase (hTERT) and induced telomere elongation. Khavinson and colleagues reported that treated cells exhibited telomere lengths 2.4-fold greater than untreated controls, with the number of cell divisions increasing from 34 to 44 passages. These findings were published in Bulletin of Experimental Biology and Medicine (2003) and remain among the most frequently cited results in Epithalon research.

More recently, a 2025 study by Ullah et al. in Theriogenology confirmed telomerase activation by Epithalon in bovine cumulus cells, reporting increased hTERT expression, improved mitochondrial membrane potential, and enhanced oocyte developmental competence following Epithalon treatment at concentrations of 0.05 mM and 0.1 mM.

Pineal Gland and Neuroendocrine Research

Epithalon's origins in pineal gland research are reflected in a body of work examining its effects on pineal tissue. In studies on aged human pineal cells, Epithalon selectively protected against age-associated mitochondrial decline, preserving membrane potential in cells derived from donors over 60 years of age while showing no significant effect on younger tissue. This age-dependent response pattern has been noted as consistent with a bioregulatory rather than pharmacological mechanism of action.

In primate models, Khavinson et al. (2001) reported that Epithalon administration in senescent monkeys was associated with modulation of melatonin secretion patterns and cortisol rhythms, suggesting interaction with the hypothalamic-pituitary axis. These findings were published in Neuroendocrinology Letters.

Antioxidant Gene Expression

A separate line of investigation has examined Epithalon's effects on cellular antioxidant pathways. In Drosophila melanogaster models, Khavinson and colleagues found that Epithalon, administered at a concentration of 0.00001% (w/w) in larval nutritional medium, reduced levels of conjugated hydroperoxides and Schiff’s bases — both markers of lipid peroxidation. The effective concentration was noted to be sufficiently low to suggest a signalling role within cellular antioxidant cascades rather than direct radical scavenging.

In human cell studies, Gutop et al. (2022) reported increased expression of genes encoding superoxide dismutase-1 (SOD-1), NAD(P)H quinone dehydrogenase 1 (NQO1), and catalase in cells exposed to Epithalon. The authors proposed that Epithalon may interact with the promoters of these antioxidant enzymes through the Keap1/Nrf2 pathway, a central regulator of the cellular oxidative stress response. These findings were published in Biochemistry (Moscow).

Further supporting these findings, Yue et al. (2022) demonstrated that Epithalon at concentrations of 0.05 mM and 0.1 mM significantly reduced intracellular reactive oxygen species (ROS) levels, reduced oocyte fragmentation, and decreased DNA damage as measured by γH2AX fluorescence intensity.

Preclinical Findings Summary

Across multiple model systems, Epithalon has been investigated for a range of cellular effects. The key areas of published research include:

Telomere biology — Telomerase activation and telomere elongation observed in human HeLa cells, fetal lung fibroblasts, and bovine cumulus cells.
Pineal tissue — Selective protection of aged human pineal cells from age-associated mitochondrial decline.
Oxidative stress — Reduction of ROS and lipid peroxidation markers in Drosophila models and mammalian cell lines; upregulation of endogenous antioxidant enzymes via Nrf2-related pathways.
Senescence markers — Reduced expression of p16 and p21 in human periodontal ligament stem cells and gingival mesenchymal stem cells following Epithalon treatment.
Immune cell populations — Modulation of CD4+ bone marrow cell populations and CD8+ splenic cell levels in aged mouse models.
Neuroprotection — Reduction of DNA damage in neurons derived from fibroblasts, with associated increases in dendritic length and junction count.

Handling and Reconstitution

Epithalon is supplied as a lyophilised (freeze-dried) powder and should be stored at -20°C for long-term stability or 2–8°C for short-term use. Once reconstituted with bacteriostatic water, the solution should be refrigerated and protected from light. Repeated freeze-thaw cycles should be avoided.

For detailed laboratory reconstitution guidance, volumetric reference concentrations, and preparation protocols, visit the Peptidex Reconstitution Reference Data page.

Certificates of Analysis

All Peptidex peptides, including Epithalon, are independently tested to verify identity and purity. Certificates of Analysis (COAs) confirming HPLC purity of >99% are available for review. To access the COA for Epithalon and all other products, visit the Certificates of Analysis page.

References

Khavinson V, Goncharova N, Lapin B. (2001). Synthetic tetrapeptide epitalon restores disturbed neuroendocrine regulation in senescent monkeys. Neuroendocrinology Letters, 22(4), 251–254.
Khavinson VKh, Bondarev IE, Butyugov AA. (2003). Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bulletin of Experimental Biology and Medicine, 135(6), 590–592. doi:10.1023/A:1025493705728
Kossoy G, Zandbank J, Tendler E, et al. (2003). Epitalon and colon carcinogenesis in rats: proliferative activity and apoptosis in colon tumors and mucosa. International Journal of Molecular Medicine, 12(4), 473–477.
Anisimov VN, Khavinson VKh, Provinciali M, et al. (2006). Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice. International Journal of Cancer, 101(1), 7–10.
Ullah R, et al. (2025). Epitalon stimulates telomerase activity and improves mitochondrial health in bovine cumulus cells and oocytes. Theriogenology.
Gutop EO, et al. (2022). Epitalon increases expression of SOD-1, NQO1, and catalase in human skin fibroblasts via Keap1/Nrf2 pathway. Biochemistry (Moscow), 87(3), 210–218.
Yue X, et al. (2022). Epitalon protects aged oocytes from oxidative stress and apoptosis in vitro. Reproductive Biology and Endocrinology, 20, 112.

All studies referenced are preclinical in nature. Epithalon is supplied by Peptidex for research use only. Not for human consumption.

Browse Epithalon at Peptidex

Buy Epithalon 10mg UK — 99%+ Purity | Peptidex →

View Reconstitution Reference Data →

View Certificates of Analysis →

Epithalon: A Research Overview of the Longevity Tetrapeptide